The public health impact of the Medicines Patent Pool increases with the fragmentation of intellectual property rights

US Public Health System Faces Inflection Point Due to Chronic Underinvestment and Fragmentation

The US public health system is at a critical inflection point, facing chronic underinvestment, workforce shortages, outdated data infrastruc

Traitements contre le cancer : «La Chine est en train de devenir le leader mondial du médicament»

China creates new regulatory pathway to accelerate access to advanced biomedical therapies

China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and

Nigeria's unregulated online herbal remedy trade puts consumers at risk

This article investigates the growing online trade in unverified herbal remedies promoted on social media in Nigeria, using the case of Oke

U.S. restrictions on Chinese biotechnology could harm patients, argues editorial

The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec

Inside the Grey Market Peptide Economy: Regulatory Gaps and Underground Pharmaceutical Infrastructure

This article investigates the parallel pharmaceutical infrastructure built around grey market peptides like BPC-157 and semaglutide. It cont